| Effects of milk supplementation with conjugated linoleic acid (isomers cis-9, trans-11 and trans-10, cis-12) on body composition and metabolic syndrome … N Laso, E Brugué, J Vidal, E Ros, JA Arnaiz, X Carné, S Vidal, S Mas, ... British journal of nutrition 98 (4), 860-867, 2007 | 103 | 2007 |
| Evidence of activation of the Toll-like receptor-4 proinflammatory pathway in patients with schizophrenia B García-Bueno, P Gassó, KS MacDowell, LF Callado, S Mas, ... Journal of Psychiatry and Neuroscience 41 (3), E46-E55, 2016 | 86 | 2016 |
| Neurotoxic/neuroprotective activity of haloperidol, risperidone and paliperidone in neuroblastoma cells P Gassó, S Mas, O Molina, M Bernardo, A Lafuente, E Parellada Progress in Neuro-Psychopharmacology and Biological Psychiatry 36 (1), 71-77, 2012 | 83 | 2012 |
| Pharmacogenetic predictors of angiotensin-converting enzyme inhibitor-induced cough: the role of: ACE:: ABO:, and: BDKRB2: genes S Mas, P Gassò, S Alvarez, J Ortiz, JM Sotoca, A Francino, X Carne, ... Pharmacogenetics and genomics 21 (9), 531-538, 2011 | 71 | 2011 |
| Inflammatory dysregulation of monocytes in pediatric patients with obsessive-compulsive disorder N Rodríguez, A Morer, EA González-Navarro, C Serra-Pages, D Boloc, ... Journal of neuroinflammation 14, 1-11, 2017 | 64 | 2017 |
| Common genetic background in anorexia nervosa and obsessive compulsive disorder: preliminary results from an association study S Mas, MT Plana, J Castro-Fornieles, P Gassó, A Lafuente, E Moreno, ... Journal of psychiatric research 47 (6), 747-754, 2013 | 60 | 2013 |
| Dopamine transporter (DAT) genotype (VNTR) and phenotype in extrapyramidal symptoms induced by antipsychotics A Lafuente, M Bernardo, S Mas, A Crescenti, M Aparici, P Gassó, ... Schizophrenia research 90 (1-3), 115-122, 2007 | 60 | 2007 |
| Protective role of Nrf2 in renal disease M Guerrero-Hue, S Rayego-Mateos, C Vázquez-Carballo, ... Antioxidants 10 (1), 39, 2020 | 59 | 2020 |
| Exon-focused genome-wide association study of obsessive-compulsive disorder and shared polygenic risk with schizophrenia J Costas, N Carrera, P Alonso, X Gurriarán, C Segalàs, E Real, ... Translational psychiatry 6 (3), e768-e768, 2016 | 59 | 2016 |
| Exon-focused genome-wide association study of obsessive-compulsive disorder and shared polygenic risk with schizophrenia J Costas, N Carrera, P Alonso, X Gurriarán, C Segalàs, E Real, ... Translational psychiatry 6 (3), e768-e768, 2016 | 59 | 2016 |
| Effect of CYP2D6, CYP2C9 and ABCB1 genotypes on fluoxetine plasma concentrations and clinical improvement in children and adolescent patients P Gassó, N Rodríguez, S Mas, M Pagerols, A Blázquez, MT Plana, ... The pharmacogenomics journal 14 (5), 457-462, 2014 | 59 | 2014 |
| A common variant in DRD3 gene is associated with risperidone-induced extrapyramidal symptoms P Gassó, S Mas, M Bernardo, S Álvarez, E Parellada, A Lafuente The pharmacogenomics journal 9 (6), 404-410, 2009 | 56 | 2009 |
| Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins/Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with … A Lafuente, M Bernardo, S Mas, A Crescenti, M Aparici, P Gasso, ... Psychiatry research 161 (2), 131-141, 2008 | 55 | 2008 |
| Modelling gene-environment interaction in first episodes of psychosis M Bernardo, M Bioque, B Cabrera, A Lobo, A González-Pinto, L Pina, ... Schizophrenia research 189, 181-189, 2017 | 54 | 2017 |
| Increased susceptibility to apoptosis in cultured fibroblasts from antipsychotic-naïve first-episode schizophrenia patients P Gassó, S Mas, O Molina, A Lafuente, M Bernardo, E Parellada Journal of psychiatric research 48 (1), 94-101, 2014 | 50 | 2014 |
| Intuitive pharmacogenetics: spontaneous risperidone dosage is related to CYP2D6, CYP3A5 and ABCB1 genotypes S Mas, P Gassò, S Alvarez, E Parellada, M Bernardo, A Lafuente The Pharmacogenomics Journal 12 (3), 255-259, 2012 | 50 | 2012 |
| CYP2D6*3, *4, *5 AND *6 POLYMORPHISMS AND ANTIPSYCHOTIC‐INDUCED EXTRAPYRAMIDAL SIDE‐EFFECTS IN PATIENTS RECEIVING … A Crescenti, S Mas, P Gassó, E Parellada, M Bernardo, A Lafuente Clinical and Experimental Pharmacology and Physiology 35 (7), 807-811, 2008 | 50 | 2008 |
| A pharmacovigilance study in first episode of psychosis: psychopharmacological interventions and safety profiles in the PEPs project M Bioque, A Llerena, B Cabrera, G Mezquida, A Lobo, A González-Pinto, ... International Journal of Neuropsychopharmacology 19 (4), pyv121, 2016 | 47 | 2016 |
| Variation in allergen content in sublingual allergen immunotherapy with house dust mites F Moreno Benítez, M Espinazo Romeu, A Letrán Camacho, S Mas, ... Allergy 70 (11), 1413-1420, 2015 | 47 | 2015 |
| Association between genetic variants related to glutamatergic, dopaminergic and neurodevelopment pathways and white matter microstructure in child and adolescent patients with … P Gassó, AE Ortiz, S Mas, A Morer, A Calvo, N Bargalló, A Lafuente, ... Journal of affective disorders 186, 284-292, 2015 | 45 | 2015 |
